Potentially harmful excipients in neonatal medications
Data from Japan show that 40% of all neonates in neonatal intensive care units received doses exceeding the acceptable daily intake of potentially harmful excipients. Exposure could be reduced by replacing these medicines with available alternatives. In our database, the data on excipients and suitability by age group, especially for premature and newborn infants, are available with just a few clicks.
The need for a pediatric Clinical Decision Support tool is highlighted
An interesting study regarding the implementation of a pediatric CPOE (Computerised Physician Order Entry) shows: "The vulnerability analysis highlighted the need to configure a Clinical Decision Support system that can identify inappropriate dosing instructions for pediatric patients." The results of the study clearly point out that the implementation of a CPOE without a Clinical Decision Support tool for pediatric dosages does not improve the number of 'inappropriate orders'.
PEDeDose meets the highest quality requirements
The new year starts with good news for pediatrics: The software behind PEDeDose has recently been certified as a Class IIa medical device. This means that we fulfil the mandatory conditions of the Medical Device Regulation as of May 2021. After meticulous testing, the conformity assessment body TÜV SÜD has confirmed that PEDeDose meets the highest requirements. To our knowledge, this makes us the only European provider of a clinical decision support tool for dosing drugs for children which meets all regulatory requirements.
Dosing errors in pediatrics - analysis of CIRS data
The results of a recently published analysis of medication errors in pediatrics - reported via CIRS - show an already well-known picture: dosing errors are by far the most common cause of critical incidents. In their recommendations for preventing medication errors, the authors particularly emphasise the correct dosage calculation and the identification of high-risk situations.
Use of CDS tools in pediatrics to be enshrined in law
A few days ago, the Swiss National Council unanimously voted in favour of legislating the use of "Clinical Decision Support" tools in pediatric clinics and in public pharmacies. This follows last year's recommendation by the Federal Council and the Council of States to approve the motion of Councillor Stöckli. Politicians are thus sending a clear signal and setting the target: Drug safety for children must be increased in Switzerland.
White paper: Safe medication for children through intelligent clinical decision support tools
In our white paper you will learn about drug safety in pediatric medicine and why children in particular are often affected by medication errors. We also show, how digitalization contributes to drug safety.
Download white paper (in German)
High heterogeneity in antibiotic dosage guidelines
A WHO comparison of five paediatric dosage guidelines for 32 commonly used antibiotics shows a significant heterogeneity. Although some differences may be justified (epidemiology, risk factors, antibiotic resistance), others cause confusion. In particular, it is criticized that in many cases neither the rationale behind the dosage recommendations nor the evidence from these sources is given.
The KIDs List - Key Potentially Inappropriate Drugs in Pediatrics
Congratulations to the Pediatric Pharmacy Association for their immense work on the KIDs List! This provides us with a list of inappropriate drugs differentiated by age of the child, including the strength of recommendation and quality of evidence. For the older population the Beers Criteria List is already well established. Let's hope that the KIDs list will also lead to an improvement in medication safety - for children!
ISO certificate confirms our high quality
As a provider of a medical devices, it is our concern to meet the highest quality standards. We are therefore pleased that PEDeus has today received the ISO 13485:2016 certificate from the notified body TÜV SÜD for "Design and Development, Production and Distribution of Pediatric Clinical Decision Support Software for Healthcare Professionals". Our quality management system thus meets the strict requirements that apply to the medical device industry in Switzerland and the EU.
PEDeus wishes Merry Christmas and all the best for the New Year
It is a long overdue Christmas present for many sick children: the Swiss Federal Council and now also the Council of States strongly support the mandatory use of "Clinical Decision Support" tools in children's hospitals and public pharmacies in order to increase the medication safety in children. We also see these signals from politics as an incentive to turn our vision into reality.
We wish you a peaceful and relaxing Chistmas season and all the best for the New Year!
Statement by the Federal Council: eHealth tools to increase drug safety in pediatrics
The Swiss Federal Council supports the use of CDS tools in pediatrics. It describes this step towards increasing the safety of medication in children as "essential and innovative". This is what the Federal Council's statement on the motion by Council of States Stöckli said.
PEDeDose integrates nationally harmonized dosages
In the near future, SwissPedDose dosages will also be available in PEDeDose. This is the national database on dosages of medicines for children, financed by the federal government. Our customers can call up the nationally harmonised recommendations directly on PEDeDose and, thanks to our integrated calculator, PEDeDose calculates the individual dosage for each patient.